Dr. Yeung Mei Wan Rebecca - Clinical Oncology
Specialist in Clinical Oncology
Highlights
- MCHK RegisteredVerified
- Specialist in Clinical OncologyBachelor of Medicine and Bachelor of Surgery (MBBS) · Fellow of the Hong Kong Academy of Medicine (Radiology) · Medical degree 1988
- InsuranceBeing compiled｜See details
About
Dr. Yeung Mei Wan Rebecca is a registered Clinical Oncology specialist in Hong Kong.
Education
Specialist in Clinical Oncology
- Bachelor of Medicine and Bachelor of Surgery (MBBS)Bachelor of Medicine and Bachelor of Surgery (MBBS)1988
- Fellow of the Hong Kong Academy of Medicine (Radiology)Fellow of the Hong Kong Academy of Medicine (Radiology)1996
Hong Kong Academy of Medicine fellowships
- FHKCRFellow, Hong Kong College of Radiologists1996
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Yeung Mei Wan Rebecca? Claim page and update insurance →
FAQ
Is Dr. Yeung Mei Wan Rebecca any good?
Dr. Yeung Mei Wan Rebecca is a registered Clinical Oncology specialist in Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Yeung Mei Wan Rebecca do?
Dr. Yeung Mei Wan Rebecca practises in Clinical Oncology.
Are you Dr. Yeung Mei Wan Rebecca? Claim this page to update and manage.
ClaimResearch and publications
6 papers
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- Effect of the underlying malignancy on critically ill septic patient's outcome.Asia-Pacific journal of clinical oncology · 2022
- Prospective Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma on Waitlist for Liver Transplant.Hepatology (Baltimore, Md.) · 2021
- Utilization of stereotactic ablative radiotherapy in oligometastatic & oligoprogressive skeletal metastases: Results and pattern of failure.Asia-Pacific journal of clinical oncology · 2019
- MRI-guided adaptive brachytherapy for locally advanced cervix cancer: Treatment outcomes from a single institution in Hong Kong.Brachytherapy · 2019
- Characterization of PD-L1 expression and immune cell infiltration in nasopharyngeal cancer.Oral oncology · 2017
- Sustained response to standard dose osimertinib in a patient with plasma T790M-positive leptomeningeal metastases from primary lung adenocarcinoma.Asia-Pacific journal of clinical oncology · 2017
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer